UNH vs ABT
By Alex · Tickerpine
UnitedHealth Group Incorporated vs Abbott Laboratories, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | UNH | ABT |
|---|---|---|
| Price | $376.59 | $101.29 |
| Market cap | $338.03B | $175.27B |
| P/E ratio | 24.2 | 32.8 |
| ROE | 14.15% | 10.58% |
| Profit margin | 3.14% | 11.65% |
| Revenue growth | 0.40% | 13.00% |
| Dividend yield | 2.46% | 2.49% |
| Beta | 0.62 | 0.59 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
UNH vs ABT in plain English
- UNH is the bigger company — about 1.9× the market cap of ABT.
- UNH is cheaper on earnings (P/E 24.2 vs 32.8).
- UNH earns a higher return on equity (14% vs 11%).
- ABT is growing revenue faster (13% vs 0%).
- ABT has the higher dividend yield (2.49% vs 2.46%).
How would $1,000 have done in each?
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
ABT return calculator
See what $1,000 in Abbott Laboratories would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.